UC Davis Medical Center

Research CenterTreats Aortic, Mitral, and Tricuspid valves

AI Description

UC Davis Medical Center’s Structural Heart Program provides evaluation and treatment for heart valve disease through a team of cardiologists, heart surgeons and interventional cardiologists. Care includes surgical and catheter-based procedures such as TAVR, transcatheter mitral and tricuspid valve replacement or repair, valve-in-valve procedures, MitraClip, paravalvular leak closure and balloon mitral valvuloplasty.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

2315 Stockton Boulevard
Sacramento, CA 95817

Clinical Trials

Upcoming

TRICAV-II

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

Public sites
31
Start date
Aug 1, 2026
Active, not recruiting

SUMMIT

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Public sites
71
Start date
Jun 15, 2018
Active, not recruiting

EARLY TAVR

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

Public sites
66
Start date
Jul 12, 2017
Recruiting

ENHANCE EFS

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

Public sites
3
Start date
Jul 2, 2026
Recruiting

CASSINI-US

Reduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

Public sites
4
Start date
Aug 5, 2026
Upcoming

EPX-HTG-2026

EPX-HTG for Structural Heart Procedures

Public sites
1
Start date
Aug 3, 2026

Nearby Centers